Jump Financial LLC boosted its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 144.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 239,895 shares of the construction company's stock after buying an additional 141,795 shares during the quarter. Jump Financial LLC owned approximately 0.29% of Aspen Aerogels worth $2,850,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of the business. XTX Topco Ltd purchased a new position in Aspen Aerogels in the fourth quarter valued at $1,019,000. Barclays PLC grew its holdings in shares of Aspen Aerogels by 16.8% during the fourth quarter. Barclays PLC now owns 107,764 shares of the construction company's stock worth $1,280,000 after purchasing an additional 15,462 shares during the last quarter. Kennedy Capital Management LLC increased its position in shares of Aspen Aerogels by 21.7% during the fourth quarter. Kennedy Capital Management LLC now owns 224,475 shares of the construction company's stock worth $2,667,000 after purchasing an additional 40,016 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Aspen Aerogels in the 4th quarter valued at about $2,909,000. Finally, Capula Management Ltd acquired a new stake in shares of Aspen Aerogels in the 4th quarter valued at about $208,000. Hedge funds and other institutional investors own 97.64% of the company's stock.
Analyst Upgrades and Downgrades
ASPN has been the topic of several research analyst reports. TD Cowen raised Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Roth Mkm reduced their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research note on Friday, February 14th. B. Riley reduced their price objective on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research note on Wednesday, February 19th. Barclays reduced their price objective on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a research note on Wednesday, February 19th. Finally, Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $19.11.
View Our Latest Analysis on ASPN
Aspen Aerogels Stock Performance
Shares of Aspen Aerogels stock traded up $0.05 during trading hours on Wednesday, hitting $5.21. 528,604 shares of the company were exchanged, compared to its average volume of 1,895,602. Aspen Aerogels, Inc. has a 1 year low of $4.80 and a 1 year high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The business has a 50-day moving average of $6.73 and a 200-day moving average of $12.06. The stock has a market capitalization of $427.77 million, a price-to-earnings ratio of 32.56 and a beta of 2.35.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.
Aspen Aerogels Company Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Read More

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.